1. Home
  2. AVBP vs ACIC Comparison

AVBP vs ACIC Comparison

Compare AVBP & ACIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVBP
  • ACIC
  • Stock Information
  • Founded
  • AVBP 2021
  • ACIC 1999
  • Country
  • AVBP United States
  • ACIC United States
  • Employees
  • AVBP N/A
  • ACIC N/A
  • Industry
  • AVBP
  • ACIC Property-Casualty Insurers
  • Sector
  • AVBP
  • ACIC Finance
  • Exchange
  • AVBP NYSE
  • ACIC Nasdaq
  • Market Cap
  • AVBP 705.8M
  • ACIC 556.0M
  • IPO Year
  • AVBP 2024
  • ACIC N/A
  • Fundamental
  • Price
  • AVBP $21.25
  • ACIC $10.80
  • Analyst Decision
  • AVBP Strong Buy
  • ACIC Buy
  • Analyst Count
  • AVBP 7
  • ACIC 1
  • Target Price
  • AVBP $39.29
  • ACIC $16.00
  • AVG Volume (30 Days)
  • AVBP 234.7K
  • ACIC 219.6K
  • Earning Date
  • AVBP 05-12-2025
  • ACIC 05-08-2025
  • Dividend Yield
  • AVBP N/A
  • ACIC 4.63%
  • EPS Growth
  • AVBP N/A
  • ACIC 3.21
  • EPS
  • AVBP N/A
  • ACIC 1.49
  • Revenue
  • AVBP N/A
  • ACIC $302,261,000.00
  • Revenue This Year
  • AVBP $63.13
  • ACIC $5.58
  • Revenue Next Year
  • AVBP N/A
  • ACIC $10.72
  • P/E Ratio
  • AVBP N/A
  • ACIC $7.34
  • Revenue Growth
  • AVBP N/A
  • ACIC 23.92
  • 52 Week Low
  • AVBP $15.47
  • ACIC $8.82
  • 52 Week High
  • AVBP $36.37
  • ACIC $15.08
  • Technical
  • Relative Strength Index (RSI)
  • AVBP 59.18
  • ACIC 41.77
  • Support Level
  • AVBP $19.80
  • ACIC $10.68
  • Resistance Level
  • AVBP $20.86
  • ACIC $10.94
  • Average True Range (ATR)
  • AVBP 1.18
  • ACIC 0.30
  • MACD
  • AVBP 0.12
  • ACIC -0.03
  • Stochastic Oscillator
  • AVBP 88.39
  • ACIC 28.40

About AVBP ARRIVENT BIOPHARMA INC

ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize the team's deep drug development experience to maximize the potential of the lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody-drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.

About ACIC American Coastal Insurance Corporation

American Coastal Insurance Corp is a holding company that underwrites commercial residential property and casualty insurance policies in the United States through its wholly-owned insurance subsidiary.

Share on Social Networks: